Therefore, in this study, we compared the AMH levels of gynecologic patients of reproductive age before receiving cancer treatment with the non-gynecological cancer patients, and we found no significant difference between AMH levels (0.965 ng/dl vs. 1.49 ng/dl; p- value 0.162). The gene discussed is AMH; the disease is cancer.